Valeant Pharmaceuticals Share Price Drops Following NYT Article

Valeant Pharmaceuticals (NYSE:VRX) share prices have dropped, following the New York Times article criticizing their drug pricing.
According to an article on RTT News:

Valeant Pharmaceuticals International is under pressure this morning after a New York Times article entitled “Valeant’s Drug Price Strategy Enriches It, but Infuriates Patients and Lawmakers.”
Valeant Pharmaceuticals International gapped open lower this morning and has continued to decline in early trade. Shares are now down 10.17 at $172.15. The stock is trading near the middle of a 1-week range.

 
Click here to read the full article from RTT News.